Jump to content
Sclero Forums
Sign in to follow this  
Guest Jude the Grouch

Abbott Seeks U.S. And E.U. Regulatory Approval For Humira® (adalimumab) In Psoriasis

Recommended Posts

Guest Jude the Grouch
Abbott Seeks U.S. And E.U. Regulatory Approval For HUMIRA® (Adalimumab) In Psoriasis. Psoriasis is a non-contagious, chronic autoimmune disease that causes the body to attack itself and create raised, inflamed, scaly, red skin lesions known as plaques, which may crack and bleed. The global submissions are based on the results of two double-blind, placebo-controlled trials of HUMIRA - REVEAL and CHAMPION. In both trials, reduction in disease activity was determined. Medical News Today. 04/02/07. (Also see: Psoriasis)

Share this post


Link to post
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
Sign in to follow this  

×